Showing 1,441 - 1,460 results of 99,663 for search '(( 50 ((ppm decrease) OR (nn decrease)) ) OR ( 5 ((ng decrease) OR (a decrease)) ))', query time: 1.34s Refine Results
  1. 1441

    TGFβ1 expression was increased, and RASAL1 expression was decreased in NTM cells in response to a hypoxic environment. by Fiona McDonnell (2636635)

    Published 2016
    “…A 0hr Control was set to 100%, and the normoxic and hypoxic results were presented as a percentage of this; Normoxic = 95.5%, Hypoxic = 159.4% (P<0.01). n = 3 *P<0.05, **P<0.01. …”
  2. 1442

    LiCl administered via 0.5% LiCl food pellets for 8 wks decreases GFAP levels in surviving <i>Gfap</i>-R236H/+ mice. by Christine M. LaPash Daniels (796881)

    Published 2015
    “…<p>(A) 81.8% (9/11) +/+ mice and 54.5% (6/11) R236H/+ mice survived 8 wks of LiCl treatment. …”
  3. 1443

    Does a correlation exist between delayed vaccination and a decreased vaccine confidence? by Virginia Reverte (9046494)

    Published 2024
    “…Vaccine Confidence Index (VCI) is an indicator to estimate confidence in vaccines, composed of simple dimensions about it and evaluated using a 5-point Likert scale. Objectives of this study, conducted in the Region of Murcia, Spain, were to determine which sociodemographic factors were associated with delayed administration in measles, mumps and rubella (MMR) vaccine, both first and second doses, and to evaluate if there were differences in parental vaccine confidence of children who were delayed on MMR vaccine schedule compare to vaccinated on time. …”
  4. 1444
  5. 1445
  6. 1446
  7. 1447
  8. 1448

    Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia by Yiting Zhang (391974)

    Published 2016
    “…Thus our findings reveal a previously unrecognized decrease in brain vitamin B<sub>12</sub> status across the lifespan that may reflect an adaptation to increasing antioxidant demand, while accelerated deficits due to GSH deficiency may contribute to neurodevelopmental and neuropsychiatric disorders.…”
  9. 1449
  10. 1450
  11. 1451
  12. 1452
  13. 1453
  14. 1454
  15. 1455
  16. 1456
  17. 1457
  18. 1458

    GSK2818713, a Novel Biphenylene Scaffold-Based Hepatitis C NS5A Replication Complex Inhibitor with Broad Genotype Coverage by Wieslaw M. Kazmierski (1706686)

    Published 2020
    “…Pan-genotype NS5A inhibitors underpin hugely successful hepatitis C virus (HCV) therapy. …”
  19. 1459
  20. 1460